These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3653576)
21. Disposition and nephrotoxicity of hexachloro-1,3-butadiene. Davis ME; Berndt WO; Mehendale HM Toxicology; 1980; 16(3):179-91. PubMed ID: 7423529 [TBL] [Abstract][Full Text] [Related]
22. Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats. Seo KW; Choung SY; Park KS; Kim HJ Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):305-17. PubMed ID: 9144837 [TBL] [Abstract][Full Text] [Related]
23. Effects of AT-125 on the nephrotoxicity of hexachloro-1,3-butadiene in rats. Davis ME Toxicol Appl Pharmacol; 1988 Aug; 95(1):44-52. PubMed ID: 2901150 [TBL] [Abstract][Full Text] [Related]
24. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Thielemans N; Lauwerys R; Bernard A Nephron; 1994; 66(4):453-8. PubMed ID: 8015651 [TBL] [Abstract][Full Text] [Related]
26. Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease. Mitić-Zlatković M; Stefanović V Ren Fail; 1999 Sep; 21(5):525-32. PubMed ID: 10516997 [TBL] [Abstract][Full Text] [Related]
27. Urinary biomarkers in hexachloro-1:3-butadiene-induced acute kidney injury in the female Hanover Wistar rat; correlation of α-glutathione S-transferase, albumin and kidney injury molecule-1 with histopathology and gene expression. Swain A; Turton J; Scudamore CL; Pereira I; Viswanathan N; Smyth R; Munday M; McClure F; Gandhi M; Sondh S; York M J Appl Toxicol; 2011 May; 31(4):366-77. PubMed ID: 21259293 [TBL] [Abstract][Full Text] [Related]
28. The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Nash JA; King LJ; Lock EA; Green T Toxicol Appl Pharmacol; 1984 Mar; 73(1):124-37. PubMed ID: 6710510 [TBL] [Abstract][Full Text] [Related]
29. Nephrotoxicity of cefotiam (CGP 14221/E) in rats and rabbits. Wachsmuth ED Arch Toxicol; 1981 Sep; 48(2-3):135-56. PubMed ID: 6271094 [TBL] [Abstract][Full Text] [Related]
30. Effect of the organic acid transport inhibitor probenecid on renal cortical uptake and proximal tubular toxicity of hexachloro-1,3-butadiene and its conjugates. Lock EA; Ishmael J Toxicol Appl Pharmacol; 1985 Oct; 81(1):32-42. PubMed ID: 4049419 [TBL] [Abstract][Full Text] [Related]
31. Land contamination and urinary abnormalities: cause for concern? Staples B; Howse ML; Mason H; Bell GM Occup Environ Med; 2003 Jul; 60(7):463-7. PubMed ID: 12819278 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside. Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298 [TBL] [Abstract][Full Text] [Related]
33. Studies on the nephrotoxicity of p-nitrophenylarsonic acid: changes in rat kidney and urinary enzyme activities following the administration of p-nitrophenylarsonic acid. Price RG Chem Biol Interact; 1979 Feb; 24(2):241-55. PubMed ID: 218743 [TBL] [Abstract][Full Text] [Related]
34. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. Hoyer JR; Mauer SM; Michael AF J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713 [TBL] [Abstract][Full Text] [Related]
35. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Thukral SK; Nordone PJ; Hu R; Sullivan L; Galambos E; Fitzpatrick VD; Healy L; Bass MB; Cosenza ME; Afshari CA Toxicol Pathol; 2005; 33(3):343-55. PubMed ID: 15805072 [TBL] [Abstract][Full Text] [Related]
36. Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage. Bomhard E; Maruhn D; Vogel O; Mager H Arch Toxicol; 1990; 64(4):269-78. PubMed ID: 2386429 [TBL] [Abstract][Full Text] [Related]
37. Early changes in renal function following chemically induced nephropathy. Wilks MF; Schmidt-Nielsen B; Stolte H Clin Physiol Biochem; 1986; 4(4):239-51. PubMed ID: 3757411 [TBL] [Abstract][Full Text] [Related]
38. Urinary enzyme excretion during renal papillary necrosis induced in rats with ethyleneimine. Ellis BG; Price RG Chem Biol Interact; 1975 Dec; 11(6):473-82. PubMed ID: 1201612 [TBL] [Abstract][Full Text] [Related]
39. Effects of cysteine and diethylmaleate pretreatments on renal function and response to a nephrotoxicant. Davis ME; Berndt WO; Mehendale HM Arch Toxicol; 1986 May; 59(1):7-11. PubMed ID: 3741149 [TBL] [Abstract][Full Text] [Related]
40. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Liu J; Habeebu SS; Liu Y; Klaassen CD Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]